Navigation Links
Epigenetics and epidemiology -- hip, hype and science
Date:3/14/2012

Epigenetics is the new hip science. Time Magazine's front cover and article, 'Why your DNA isn't your Destiny' from January 2010 explains why. Its more explicit subtitle provided the hook - 'The new science of epigenetics reveals how the choices you make can change your genes - and those of your kids'. Who wouldn't be interested in this?

Epigenetics is the study of ways in which the genetic code in our DNA is regulated - switching genes on and off, or amplifying or muting their expression - results in changes in metabolic pathways and in bodily functions. The exciting thing is that epigenetic marks that can be detected by new biotechnology are affected by modifiable environmental factors, like nutrition. This potential makes epigenetics an exciting field of research with important implications for disease mechanisms and of huge commercial interest to those in the business of generating new drugs.

Slightly more cautious in its approach than TIME magazine it has taken the International Journal of Epidemiology (IJE) another 2 years to produce an issue devoted to epigenetics. Sadly for those hopeful of imprinting the advantages of their environment on their genes to the benefit of their children and grandchildren, the picture presented in the March issue of the IJE is not so optimistic about the potential for environmentally induced epigenetic changes to persist across generations. While increasingly sophisticated genetic tests make it possible for parents to choose some specific traits of their baby, the epigenetic designer baby may prove to be a non-starter.

Given the huge range of epigenetic variation and the relatively small effect size of environmental influences on the epigenome, investigation at the level of the individual may produce little but random noise. However, the IJE is confident that, studied at the population level, epigenetics has much to offer to the understanding of disease aetiology and epidemiology has much to offer the field of epigenetics.

To begin at the beginning, the IJE has reprinted Conrad Waddington's seminal paper, which is brought up-to-date by commentaries from experts currently at the cutting edge of the field. This is followed by a series of papers on epigenetics that reflect the breadth and depth of current epidemiological contributions, ranging from studies of socio-economic differences in epigenetic patterns to new methods to determine the causal contribution of epigenetic processes. These empirical contributions are complimented by a stimulating and accessible commentary on the relationship between epidemiology and epigenetics by Bastiaan Heijmans and Jonathon Mill.

Further reflection is provided by a symposium based on a short book 'Plasticity, Robustness, Development and Evolution' by Patrick Bateson and Peter Gluckman, which covers the most recent developments at the intersection of developmental and evolutionary biology. A prcis of the book, written by the authors, starts a debate that presents arguments in favour of the wider incorporation of epigenetics into epidemiology as well as cautioning against the dismissal of the genetic heritability in the rush to adopt new methods.

This epigenetics issue is edited by Caroline Relton and George Davey Smith. Caroline, from the Institute of Genetic Medicine at Newcastle University whose research focuses on understanding the effect of epigenetic variation on health, says "Epigenetics has begun to permeate many aspects of medical research, as well as many corners of the popular press, in a bid to explain how the environment and genome act in concert to shape the biological processes that cause disease. Epidemiology a discipline that aims to improve our understanding of the determinants of disease - has much to offer the field of epigenetics, not least in helping to distinguish those epigenetic events that are on the causal pathway to disease from those that are not. This information is crucial if epigenetics is to be incorporated into strategies to predict, prevent and treat disease aspirations that are already widely proposed."


'/>"/>

Contact: Gabby Fletcher
gabby.fletcher@oup.com
44-186-535-3969
Oxford University Press
Source:Eurekalert

Related biology news :

1. Ali Shilatifard and colleagues aim to clarify the definition of epigenetics
2. New nucleotide could revolutionize epigenetics
3. New piece found in the puzzle of epigenetics
4. Epigenetics could help researchers determine any risks associated with low-dose radiation
5. Study finds diet and alcohol alter epigenetics of breast cancer
6. Largest ever epigenetics project launched
7. Adult stem cells carry their own baggage: Epigenetics guides stem cell fate
8. New international Ph.D. program on Dynamics of Gene Regulation, Epigenetics and DNA Damage Response
9. Inherited epigenetics produced record fast evolution
10. The challenges of avian influenza virus: Mechanism, epidemiology and control
11. Penn presents inaugural symposium on applied mathematics and computational science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... , Feb. 7, 2017   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... , its innovative, highly flexible and award winning eClinical ... customers. iMedNet is a proven Software-as-a-Service (SaaS) ... Data Capture (EDC), but also delivers an entire suite ...
(Date:2/6/2017)... According to Acuity Market Intelligence, ongoing ... to continue to embrace biometric and digital identification ... Border Control (ABC) eGates and 1436 Automated Passport ... 163 ports of entry across the globe. Deployments ... combined CAGR of 37%. APC Kiosks reached 75% ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Blood Corporation (NYSE: CO ) ("CCBC" or ... laboratory testing, hematopoietic stem cell processing and stem cell ... the third quarter and first nine months of fiscal ... Quarter of Fiscal 2017 Highlights Revenues ... 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)... 23, 2017 China Biologic Products, Inc. (NASDAQ: CBPO) ... biopharmaceutical company in China, today announced its financial results for ... Fourth Quarter 2016 Financial Highlights ... 21.7% in RMB terms, or increased by 13.6% in USD ... quarter of 2015. Gross profit increased by ...
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
Breaking Biology Technology: